Editorial comment on: Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Montironi
Rodolfo
R
Scarpelli
Marina
M
Lopez-Beltran
Antonio
A
Cheng
Liang
L
D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics; D002277:Carcinoma / Q000737:chemistry* / Q000235:genetics / Q000401:mortality / Q000473:pathology; D049109:Cell Proliferation; D018572:Disease-Free Survival; D019332:Endothelin-1 / Q000032:analysis*; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis; D009154:Mutation; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D044022:Receptor, Endothelin A / Q000032:analysis*; D044023:Receptor, Endothelin B / Q000032:analysis; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000235:genetics; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D001749:Urinary Bladder Neoplasms / Q000737:chemistry* / Q000235:genetics / Q000401:mortality / Q000473:pathology; D019459:Urothelium / Q000737:chemistry / Q000473:pathology
D014408:Biomarkers, Tumor; D019332:Endothelin-1; D019394:Ki-67 Antigen; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; C496365:FGFR3 protein, human; D051498:Receptor, Fibroblast Growth Factor, Type 3